Huntington disease and related disorders
MONDO:0000167A grouping for Huntington disease and similar diseases.
91 clinical trials for this condition and its sub-types, 0 tagged with Huntington disease and related disorders itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Huntington disease and related disorders
-
Huntington disease 76 trials
2 sub-types
- Juvenile Huntington disease 1 trial
- Westphal disease 0 trials
-
Huntington disease-like syndrome 0 trials · 17 incl. sub-types
10 sub-types
- Machado-Joseph disease 11 trials Sub-types →
- Spinocerebellar ataxia type 1 10 trials
- Spinocerebellar ataxia type 2 10 trials Sub-types →
- Dentatorubral-pallidoluysian atrophy 4 trials
- Huntington disease-like 3 0 trials
- Huntington disease-like syndrome due to C9ORF72 expansions 0 trials
- Childhood-onset benign chorea with striatal involvement 0 trials
- Neuroacanthocytosis 0 trials Sub-types →
- Neuroferritinopathy 0 trials
- Spinocerebellar ataxia type 17 0 trials
Most studied deeper sub-types
-
Huntington's drug safety study halted early
Disease control Stopped earlyThis study aimed to see if the drug SAGE-718 is safe for people with Huntington's disease when taken over a long period. It was an open-label study, meaning everyone knew they were getting the drug. The study was terminated early, so results are limited.
Phase 3 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Experimental drug aims to curb disinhibition in dementia patients
Symptom relief Stopped earlyThis study tested a drug called AVP-786 to see if it could safely reduce disinhibition—impulsive or inappropriate behavior—in people with neurodegenerative disorders like Alzheimer's or frontotemporal dementia. The trial planned to include many participants but was terminated ear…
Phase 2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC